These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29680992)

  • 1. Comparison of mucosal and mucoperiosteal wound cover for the treatment of medication-related osteonecrosis of the jaw lesions: a retrospective cohort study.
    Nonnenmühlen N; Burnic A; Bartella A; Lethaus B; Gerhards F; Ristow O; Pautke C; Hölzle F; Steiner T
    Clin Oral Investig; 2019 Jan; 23(1):351-359. PubMed ID: 29680992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
    Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
    Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasolabial Flap Improves Healing in Medication-Related Osteonecrosis of the Jaw.
    Lemound J; Muecke T; Zeller AN; Lichtenstein J; Eckardt A; Gellrich NC
    J Oral Maxillofac Surg; 2018 Apr; 76(4):877-885. PubMed ID: 29104029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw - A single center cohort study.
    Ristow O; Rückschloß T; Bodem J; Berger M; Bodem E; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2018 May; 46(5):815-824. PubMed ID: 29631942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: A prospective cohort study.
    Otto S; Ristow O; Pache C; Troeltzsch M; Fliefel R; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2016 Aug; 44(8):1073-80. PubMed ID: 27263757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
    Hasegawa T; Kawakita A; Ueda N; Funahara R; Tachibana A; Kobayashi M; Kondou E; Takeda D; Kojima Y; Sato S; Yanamoto S; Komatsubara H; Umeda M; Kirita T; Kurita H; Shibuya Y; Komori T;
    Osteoporos Int; 2017 Aug; 28(8):2465-2473. PubMed ID: 28451732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of open and closed management after surgical treatments in patients with medication-related osteonecrosis of the jaw.
    Eguchi T; Basugi A; Kawaguchi K; Sato K; Hamada Y
    J Stomatol Oral Maxillofac Surg; 2022 Feb; 123(1):27-30. PubMed ID: 33429066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of advanced medication-related osteonecrosis of the jaws: Comparison of soft tissue closure techniques and evaluation of side effects.
    Ahrenbog G; Gottsauner M; Meier JK; Ettl T; Reichert TE; Klingelhöffer C
    J Craniomaxillofac Surg; 2020 Sep; 48(9):896-901. PubMed ID: 32811717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab.
    Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ
    Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of stage 2 medication-related osteonecrosis of the jaw compared to osteomyelitis.
    Kang SH; Won YJ; Kim MK
    Cranio; 2018 Nov; 36(6):373-380. PubMed ID: 28854059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
    Lopes RN; Rabelo GD; Rocha AC; Carvalho PA; Alves FA
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1288-95. PubMed ID: 25871903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bone perfusion through cortical perforations to improve healing of medication-related osteonecrosis of the jaw: a retrospective study.
    Guo Y; Guo C
    Int J Oral Maxillofac Surg; 2021 Jun; 50(6):740-745. PubMed ID: 33023802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?
    Fleisher KE; Pham S; Raad RA; Friedman KP; Ghesani M; Chan KC; Amintavakoli N; Janal M; Levine JP; Glickman RS
    J Oral Maxillofac Surg; 2016 May; 74(5):945-58. PubMed ID: 26657395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study.
    Giudice A; Barone S; Diodati F; Antonelli A; Nocini R; Cristofaro MG
    J Oral Maxillofac Surg; 2020 Nov; 78(11):1986-1999. PubMed ID: 32615096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Challenges in Soft Tissue Reconstruction in Patients With MRONJ - The Nasolabial Flap.
    Dudde F; Barbarewicz F; Henkel KO
    Anticancer Res; 2023 Aug; 43(8):3709-3713. PubMed ID: 37500150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O; Rückschloß T; Müller M; Berger M; Kargus S; Pautke C; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
    Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study.
    Ristow O; Otto S; Geiß C; Kehl V; Berger M; Troeltzsch M; Koerdt S; Hohlweg-Majert B; Freudlsperger C; Pautke C
    Int J Oral Maxillofac Surg; 2017 Feb; 46(2):157-166. PubMed ID: 27856150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of severe medication-related osteonecrosis of the jaw.
    Feng Z; An J; Zhang Y; He Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):43-51. PubMed ID: 38596940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the surgical treatment of maxillary medication-related osteonecrosis of the jaw].
    Tian M; Wang DN; Luo SY; Zhai YW; Sun GW
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 May; 56(5):447-451. PubMed ID: 33904279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.